SIGN UP

Albert Bourla, Pfizer CEO (Markus Schreiber/AP Images)

January 30, 2024 07:32 AM ESTUpdated 08:03 AM

Pfizer's Q4 revenue tumbles 42% amid Covid reset

Katherine Lewin

News Reporter

Pfizer rounded out a tough year with fourth-quarter revenue of $14.2 billion, a 42% decrease compared to the same time in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

TRENDING NOW

To lead NIH, Trump taps Stanford academic and pandemic response critic Jay Bhattacharya

PTC reports Phase 2 ALS fail, sells priority review voucher for $150M

FDA is looking into hematology risks after patients take Bluebird's Skysona gene therapy

Applied Therapeutics' rare disease drug gets a CRL

Novartis to cut 139 jobs in NJ as part of commercial refocus

Updated: Amgen obesity shot shows 20% weight loss, but dosing questions hang over readout